Stocks Comparison
Cadre vs Zimmer Biomet: revenue, profit, margins and growth compared
Cadre brought in $610.3M of revenue in fiscal 2025, Zimmer Biomet $8.2B in fiscal 2025. Revenue changed by +7.5% at Cadre and +7.2% at Zimmer Biomet on the year before, so Cadre grew faster. Cadre kept 7.2% of its revenue as net profit, Zimmer Biomet 8.6%. Free cash flow was $56.8M at Cadre and $1.5B at Zimmer Biomet.
Side by side, latest fiscal year
| CDRE | ZBH | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $610.3M | $8.2B |
| Revenue growth | +7.5% | +7.2% |
| Net income | $44.1M | $705.1M |
| Net margin | 7.2% | 8.6% |
| Free cash flow | $56.8M | $1.5B |
| Free cash flow margin | 9.3% | 17.9% |
| Earnings per share (diluted) | $1.02 | $3.55 |
| Cash | $122.9M | $591.9M |
| Debt | $307.3M | $7.5B |
| Price to earnings | 25.9 | 25.6 |
| Market value | $1.1B | $17.4B |
| Dividend yield | 0.36% | 1.05% |
| Rank by revenue in sector | #179 of 523 · Health care | #51 of 523 · Health care |
Over the years
Questions about Cadre and Zimmer Biomet
Which is bigger by revenue, Cadre or Zimmer Biomet?
Zimmer Biomet is bigger by revenue: $8.2B in fiscal 2025, against $610.3M for Cadre in fiscal 2025.
Which keeps more of its revenue as profit, Cadre or Zimmer Biomet?
Cadre had a net margin of 7.2% in fiscal 2025; Zimmer Biomet had 8.6% in fiscal 2025.
Which grew revenue faster, Cadre or Zimmer Biomet?
In their latest fiscal years revenue changed by +7.5% at Cadre and +7.2% at Zimmer Biomet.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.